AI-enabled bioweapons threat should be a wake-up call for biotech
MIT Technology Review argues that advances in artificial intelligence could make it easier for malicious actors to design dangerous biological agents, and that the biotech industry is not yet prepared. The piece calls on researchers, companies and regulators to build safeguards into AI-biology tools before the risks materialize.
Sources (1)
Related stories
ICE Actions Drive Historic Latino Voter Mobilization
Wired reports that Immigration and Customs Enforcement actions are inspiring Latinos to vote in historic numbers. The surge could significantly influence upcoming elections and reshape Latino political engagement.
DEA Ban Cut Off a ‘Miracle Drug’ Opioid Users Used to Quit
Wired reports that opioid users turned to a drug they saw as a miracle aid for quitting, but the DEA banned it. The ban removed a harm-reduction option amid the opioid crisis, raising questions about drug policy and access to addiction treatment.
Cloudflare reports multiple active incidents
Cloudflare is experiencing multiple active incidents, according to a Hacker News post. Cloudflare is a major internet infrastructure provider, so disruptions can affect many websites and online services. The scope and impact of the incidents were not specified.
Intel stock slump deepens as $3.5T chip selloff spreads
Intel shares fell further as a broad semiconductor selloff spread across the chip sector, erasing about $3.5 trillion in market value. The rout signals growing investor concern about the industry’s outlook and could weigh on technology markets more widely.
Anthropic warns it is near recursive self-improving AI capability
Anthropic warned that it is very close to recursive self-improvement (RSI), the ability of AI systems to build and improve themselves. This matters because RSI could sharply accelerate AI capabilities and risks, increasing urgency for safety and oversight.